KB Financial Partners’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$51K Buy
317
+99
+45% +$22.2K 0.01% 252
2023
Q2
$63K Hold
218
0.02% 240
2023
Q1
$70K Sell
218
-37
-15% -$11K 0.02% 233
2022
Q4
$75K Sell
255
-24
-9% -$6.62K 0.03% 232
2022
Q3
$64K Hold
279
0.02% 232
2022
Q2
$61K Buy
279
+29
+12% +$6.59K 0.02% 238
2022
Q1
$67K Sell
250
-21
-8% -$5.15K 0.02% 247
2021
Q4
$72K Buy
+271
New +$78.6K 0.02% 253
2021
Q3
Sell
-277
Closed -$76K 468
2021
Q2
$76K Sell
277
-204
-42% -$55.5K 0.03% 228
2021
Q1
$126K Buy
+481
New +$129K 0.05% 192

Other funds holding PODD

KB Financial Partners's PODD Position: Q3 2023 in Review

KB Financial Partners increased its Insulet (PODD) stake by 45% in Q3 2023, buying an estimated $22.2K and bringing the position to 317 shares worth $51K. The position accounts for 0.01% of the portfolio, ranked #252.

KB Financial Partners first reported a position in PODD in Q1 2021 and has held it in 10 quarters since. The position peaked at $126K in Q1 2021. 528 funds tracked by Wall St. Rank hold PODD as of Q3 2023.

  • KB Financial Partners held 317 shares of Insulet worth $51K as of Q3 2023.
  • KB Financial Partners bought 99 Insulet shares in Q3 2023, an estimated $22.2K.
  • Insulet made up 0.01% of KB Financial Partners's portfolio in Q3 2023, its #252 holding.
  • KB Financial Partners first reported a position in Insulet in Q1 2021 and has held it in 10 quarters since.
  • KB Financial Partners's Insulet position peaked at $126K in Q1 2021.
  • 528 funds tracked by Wall St. Rank held Insulet as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.